Organogenesis Holdings Inc. (ORGO) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Organogenesis Holdings Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.520 -- 00:00:05.525 Welcome, ladies and gentlemen, to the first quarter 2025 earnings conference call for 00:00:05.525 -- 00:00:10.691 Organogenesis Holdings, Inc. At this time, all participants have been placed in a listen-only 00:00:10.691 -- 00:00:14.795 mode. Please note that this conference call is being recorded and that the recording 00:00:14.795 -- 00:00:18.379 will be available on the company's website for replay shortly. 00:00:18.379 -- 00:00:22.803 Before we begin, I would like to remind everyone that our remarks today may contain forward-looking 00:00:22.803 -- 00:00:27.268 statements that are based on the current expectations of management and involve inherent 00:00:27.268 -- 00:00:31.440 risks and uncertainties That could cause actual results to differ materially from those 00:00:31.440 -- 00:00:35.846 indicated, including the risks and uncertainties described in the company's filings with 00:00:35.846 -- 00:00:41.152 the Securities and Exchange Commission, including item 1A, risk factors of the company's 00:00:41.152 -- 00:00:46.119 most recent annual report and its subsequently filed quarterly reports. 00:00:46.119 -- 00:00:50.505 You are cautioned not to place undue reliance upon any forward-looking statements which 00:00:50.505 -- 00:00:55.554 speak only as of the date made. Although it may voluntarily do so from time to time, 00:00:55.554 -- 00:01:00.040 the company undertakes no commitment to update or revise the forward-looking statements, 00:01:00.040 -- 00:01:04.807 whether as a result of new information, future events, or otherwise, except as required 00:01:04.807 -- 00:01:10.395 by applicable securities laws. This call will also include references to certain 00:01:10.395 -- 00:01:14.861 financial measures that are not calculat...